Researchers surveyed more than 1,500 consumers and almost 600 physicians.
Here are five notes:
1. Other studies have found only 4 percent of cancer patients enroll in clinical trials annually.
2. Forty percent of respondents reported having a positive overall impression of clinical trials.
3. After receiving education about clinical trials, 40 percent to 60 percent of respondents reported viewing clinical trials positively, overall.
4. Consumer barriers to clinical trial enrollment include worry over its side effects (55 percent); uncertainty about insurance and out-of-pocket costs (50 percent); inconvenient trial location (48 percent); concern about getting a placebo (46 percent); skepticism of a treatment that is not yet proven to work (35 percent); and concern over feeling like “guinea pigs” (34 percent).
5. Physicians cited barriers such as getting a placebo (63 percent), safety (63 percent) feeling like “guinea pgs” (53 percent).
More articles on quality & infection control:
Black Book Research places Modernizing Medicine at #1 — 4 highlights
Tension builds as legislators debate Zika funding: 3 notes
Understanding human flaws could cause less medical errors — 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.